The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prokinetic Drug Market Research Report 2024
Synopsis
A prokinetic agent (also gastroprokinetic agent, gastrokinetic agent or propulsive) is a type of drug which enhances gastrointestinal motility by increasing the frequency or strength of contractions, but without disrupting their rhythm. They are used to treat certain gastrointestinal symptoms, including abdominal discomfort, bloating, constipation, heart burn, nausea, and vomiting; and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.
The global Prokinetic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prokinetic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prokinetic Drug.
Report Scope
The Prokinetic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prokinetic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prokinetic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sumitomo
Johnson & Johnson
Sanofi
Kyowa Kirin Pharmaceuticals
Pfizer
Teva
Cadila Pharmaceuticals
Hanmi Pharm
Segment by Type
Metoclopramide
Domperidone
Cisapride
Others
Segment by Application
Gastroparesis
Constipation
Reflux Esophagitis
Functional Dyspepsia
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prokinetic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prokinetic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A prokinetic agent (also gastroprokinetic agent, gastrokinetic agent or propulsive) is a type of drug which enhances gastrointestinal motility by increasing the frequency or strength of contractions, but without disrupting their rhythm. They are used to treat certain gastrointestinal symptoms, including abdominal discomfort, bloating, constipation, heart burn, nausea, and vomiting; and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.
The global Prokinetic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prokinetic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prokinetic Drug.
Report Scope
The Prokinetic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prokinetic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prokinetic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sumitomo
Johnson & Johnson
Sanofi
Kyowa Kirin Pharmaceuticals
Pfizer
Teva
Cadila Pharmaceuticals
Hanmi Pharm
Segment by Type
Metoclopramide
Domperidone
Cisapride
Others
Segment by Application
Gastroparesis
Constipation
Reflux Esophagitis
Functional Dyspepsia
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prokinetic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prokinetic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Prokinetic Drug Market Overview
1.1 Product Overview and Scope of Prokinetic Drug
1.2 Prokinetic Drug Segment by Type
1.2.1 Global Prokinetic Drug Market Value Comparison by Type (2024-2030)
1.2.2 Metoclopramide
1.2.3 Domperidone
1.2.4 Cisapride
1.2.5 Others
1.3 Prokinetic Drug Segment by Application
1.3.1 Global Prokinetic Drug Market Value by Application: (2024-2030)
1.3.2 Gastroparesis
1.3.3 Constipation
1.3.4 Reflux Esophagitis
1.3.5 Functional Dyspepsia
1.4 Global Prokinetic Drug Market Size Estimates and Forecasts
1.4.1 Global Prokinetic Drug Revenue 2019-2030
1.4.2 Global Prokinetic Drug Sales 2019-2030
1.4.3 Global Prokinetic Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Prokinetic Drug Market Competition by Manufacturers
2.1 Global Prokinetic Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Prokinetic Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Prokinetic Drug Average Price by Manufacturers (2019-2024)
2.4 Global Prokinetic Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prokinetic Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prokinetic Drug, Product Type & Application
2.7 Prokinetic Drug Market Competitive Situation and Trends
2.7.1 Prokinetic Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prokinetic Drug Players Market Share by Revenue
2.7.3 Global Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prokinetic Drug Retrospective Market Scenario by Region
3.1 Global Prokinetic Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Prokinetic Drug Global Prokinetic Drug Sales by Region: 2019-2030
3.2.1 Global Prokinetic Drug Sales by Region: 2019-2024
3.2.2 Global Prokinetic Drug Sales by Region: 2025-2030
3.3 Global Prokinetic Drug Global Prokinetic Drug Revenue by Region: 2019-2030
3.3.1 Global Prokinetic Drug Revenue by Region: 2019-2024
3.3.2 Global Prokinetic Drug Revenue by Region: 2025-2030
3.4 North America Prokinetic Drug Market Facts & Figures by Country
3.4.1 North America Prokinetic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Prokinetic Drug Sales by Country (2019-2030)
3.4.3 North America Prokinetic Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prokinetic Drug Market Facts & Figures by Country
3.5.1 Europe Prokinetic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Prokinetic Drug Sales by Country (2019-2030)
3.5.3 Europe Prokinetic Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prokinetic Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Prokinetic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Prokinetic Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Prokinetic Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prokinetic Drug Market Facts & Figures by Country
3.7.1 Latin America Prokinetic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Prokinetic Drug Sales by Country (2019-2030)
3.7.3 Latin America Prokinetic Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prokinetic Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Prokinetic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Prokinetic Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Prokinetic Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prokinetic Drug Sales by Type (2019-2030)
4.1.1 Global Prokinetic Drug Sales by Type (2019-2024)
4.1.2 Global Prokinetic Drug Sales by Type (2025-2030)
4.1.3 Global Prokinetic Drug Sales Market Share by Type (2019-2030)
4.2 Global Prokinetic Drug Revenue by Type (2019-2030)
4.2.1 Global Prokinetic Drug Revenue by Type (2019-2024)
4.2.2 Global Prokinetic Drug Revenue by Type (2025-2030)
4.2.3 Global Prokinetic Drug Revenue Market Share by Type (2019-2030)
4.3 Global Prokinetic Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Prokinetic Drug Sales by Application (2019-2030)
5.1.1 Global Prokinetic Drug Sales by Application (2019-2024)
5.1.2 Global Prokinetic Drug Sales by Application (2025-2030)
5.1.3 Global Prokinetic Drug Sales Market Share by Application (2019-2030)
5.2 Global Prokinetic Drug Revenue by Application (2019-2030)
5.2.1 Global Prokinetic Drug Revenue by Application (2019-2024)
5.2.2 Global Prokinetic Drug Revenue by Application (2025-2030)
5.2.3 Global Prokinetic Drug Revenue Market Share by Application (2019-2030)
5.3 Global Prokinetic Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sumitomo
6.1.1 Sumitomo Corporation Information
6.1.2 Sumitomo Description and Business Overview
6.1.3 Sumitomo Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sumitomo Prokinetic Drug Product Portfolio
6.1.5 Sumitomo Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Prokinetic Drug Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Prokinetic Drug Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Kyowa Kirin Pharmaceuticals
6.4.1 Kyowa Kirin Pharmaceuticals Corporation Information
6.4.2 Kyowa Kirin Pharmaceuticals Description and Business Overview
6.4.3 Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kyowa Kirin Pharmaceuticals Prokinetic Drug Product Portfolio
6.4.5 Kyowa Kirin Pharmaceuticals Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Prokinetic Drug Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Prokinetic Drug Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Cadila Pharmaceuticals
6.6.1 Cadila Pharmaceuticals Corporation Information
6.6.2 Cadila Pharmaceuticals Description and Business Overview
6.6.3 Cadila Pharmaceuticals Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cadila Pharmaceuticals Prokinetic Drug Product Portfolio
6.7.5 Cadila Pharmaceuticals Recent Developments/Updates
6.8 Hanmi Pharm
6.8.1 Hanmi Pharm Corporation Information
6.8.2 Hanmi Pharm Description and Business Overview
6.8.3 Hanmi Pharm Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hanmi Pharm Prokinetic Drug Product Portfolio
6.8.5 Hanmi Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prokinetic Drug Industry Chain Analysis
7.2 Prokinetic Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prokinetic Drug Production Mode & Process
7.4 Prokinetic Drug Sales and Marketing
7.4.1 Prokinetic Drug Sales Channels
7.4.2 Prokinetic Drug Distributors
7.5 Prokinetic Drug Customers
8 Prokinetic Drug Market Dynamics
8.1 Prokinetic Drug Industry Trends
8.2 Prokinetic Drug Market Drivers
8.3 Prokinetic Drug Market Challenges
8.4 Prokinetic Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
